Skip to main content
. 2022 Apr 30;12(6):1313–1323. doi: 10.1007/s13555-022-00733-x

Fig. 2.

Fig. 2

Fluorescence imaging of dermal biomarker patches. DBP were chemically modified adjacent to the microneedles with T24 oligonucleotides and then CY3-A24 hybridized for imaging. Strong fluorescence between the modified and unmodified regions can be seen and was quantified using ImageJ. A Fluorescence imaging of the DBP; B fluorescence imaging of spot on the DBP backplate used for quantitative assessment of chemical modification